Find out about our strategy for continued growth and enhancing our market position
At ROVI, we don't believe in borders
Reach more countries and more people.
To date, thanks to our 22 alliances with international partners, our principal product, Bemiparin, is now present in more than 55 countries.
With our Enoxaparin Biosimilar, we hope to increase our presence in Europe, the United States and emerging countries.
Our profile and our experience in the Spanish market make us an attractive
licensee for the successful marketing of new products
Nowadays, we offer product licenses to third parties:
Our international molecule
Our biosimilar with high
Chondroitin Sulphate ROVI 400mg
Our Class III health product with CE marking